Conditional ablation of Pten in osteoprogenitors stimulates FGF signaling

Development

Volumn 138, Issue 7, 2011, Pages 1433-1444

  Guntur, Anyonya R ^a   Reinhold, Martina I ^b   Cuellar Jr , Joe ^b   Naski, Michael C ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

Dermo1cre; Endochondral ossification; FGF18; Mouse; Osteoprogenitors; Perichondrium; Pten

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 18; MITOGEN ACTIVATED PROTEIN KINASE; NERVE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN GLI2; PROTEIN SPRY2; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MATRIX; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE DELETION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; STEM CELL;

ANIMALS; BLOTTING, WESTERN; BONE AND BONES; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLAST GROWTH FACTORS; IN SITU NICK-END LABELING; MESENCHYMAL STEM CELLS; MICE; MICE, TRANSGENIC; OSTEOBLASTS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ERINACEIDAE; MUS;

EID: 79955136750     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.058016     Document Type: Article

References (45)

1. Ambrogini, E., Maria, A., Marta, M.-M., Ji-Hye, P., Ronald, A. D., Li, H., Goellner, J., Weinstein, R. S., Jilka, R. L., O'Brien, C. A. et al. (2010). FoxOmediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 11, 136-146.
2. Brewster, R., Mullor, J. L. and Ruiz i Altaba, A. (2000). Gli2 functions in FGF signaling during antero-posterior patterning. Development 127, 4395-4405.
3. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
4. Colnot, C., Lu, C., Hu, D. and Helms, J. A. (2004). Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev. Biol. 269, 55-69.
5. Cooper, M. K., Wassif, C. A., Krakowiak, P. A., Taipale, J., Gong, R., Kelley, R. I., Porter, F. D. and Beachy, P. A. (2003). A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat. Genet. 33, 508-513.
6. Ford-Hutchinson, A. F., Ali, Z., Lines, S. E., Hallgrímsson, B., Boyd, S. K. and Jirik, F. R. (2007). Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth. J. Bone Miner. Res. 22, 1245-1259.
7. Geng, H., Lan, R., Wang, G., Siddiqi, A. R., Naski, M. C., Brooks, A. I., Barnes, J. L., Saikumar, P., Weinberg, J. M. and Venkatachalam, M. A. (2009). Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia. Am. J. Pathol. 174, 1291-1308.
8. Gross, I., Bassit, B., Benezra, M. and Licht, J. D. (2001). Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J. Biol. Chem. 276, 46460-46468.
9. Hacohen, N., Kramer, S., Sutherland, D., Hiromi, Y. and Krasnow, M. A. (1998). sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92, 253-263.
10. Hsieh, S.-C., Chen, N.-T. and Lo, S. H. (2009). Conditional loss of PTEN leads to skeletal abnormalities and lipoma formation. Mol. Carcinog. 48, 545-552.
11. Kapadia, R. M., Guntur, A. R., Reinhold, M. I. and Naski, M. C. (2005). Glycogen synthase kinase 3 controls endochondral bone development: contribution of fibroblast growth factor 18. Dev. Biol. 285, 496-507.
12. Karsenty, G. (1999). The genetic transformation of bone biology. Genes Dev. 13, 3037-3051.
13. Kronenberg, H. (2003). Developmental regulation of the growth plate. Nature 423, 332.
14. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R. et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
15. Li, L., Cserjesi, P. and Olson, E. N. (1995). Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev. Biol. 172, 280-292.
16. Liu, X., Bruxvoort, K. J., Zylstra, C. R., Liu, J., Cichowski, R., Faugere, M.-C., Bouxsein, M. L., Wan, C., Williams, B. O. and Clemens, T. L. (2007). Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc. Natl. Acad. Sci. USA 104, 2259-2264.
17. Liu, Z., Xu, J., Colvin, J. S. and Ornitz, D. M. (2002). Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16, 859.
18. Livak, K. J. and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Methods 25, 402-408.
19. McLeod, M. J. (1980). Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22, 299-301.
20. Miraoui, H. and Marie, P. J. (2010). Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci. Signal. 3, re9.
21. Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W. and Malcolm, S. (1994). A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8, 269-274.
22. Myers, M. P., Pass, I., Batty I, H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P. and Tonks, N. K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. USA 95, 13513-13518.
23. Naski, M. C., Wang, Q., Xu, J. and Ornitz, D. M. (1996). Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13, 233-237.
24. Naski, M. C., Colvin, J. S., Coffin, J. D. and Ornitz, D. M. (1998). Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125, 4977-4988.
25. Ohbayashi, N., Shibayama, M., Kurotaki, Y., Imanishi, M., Fujimori, T., Itoh, N. and Takada, S. (2002). FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870-879.
26. Ornitz, D. M. (2005). FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16, 205-213.
27. Pagès, G., Lenormand, P., Allemain, G., Chambard, J. C., Meloche. S. and Pouyssagur, J. (1993). Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90, 8319-8323.
28. Paik, J.-H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R. et al. (2007). FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323.
29. Peng, X.-D., Xu, P.-Z., Chen, M.-L., Windgassen, A. H., Skeen, J., Jacobs, J., Sundararajan, D., Chen, W. S., Crawford, S. E., Coleman, K. G. et al. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17, 1352-1365.
30. Rached, M.-T., Kode, A., Silva, B. C., Jung, D. Y., Gray, S., Ong, H., Paik, J.-H., DePinho, R. A., Kim, J. K., Karsenty, G. et al. (2010). FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Invest. 120, 357-368.
31. Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M. and Malcolm, S. (1994). Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat. Genet. 8, 98.
32. Reinhold, M. I. and Naski, M. C. (2007). Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J. Biol. Chem. 282, 3653-3663.
33. Reinhold, M. I., Kapadia, R. M., Liao, Z. and Naski, M. C. (2006). The Wntinducible transcription factor Twist1 inhibits chondrogenesis. J. Biol. Chem. 281, 1381-1388.
34. Riobó, N. A., Lu, K., Ai, X., Haines, G. M. and Emerson, C. P., Jr. (2006). Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc. Natl. Acad. Sci. USA 103, 4505-4510.
35. Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J. M., Maroteaux, P., Le Merrer, M. and Munnich, A. (1994). Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252.
36. Seger, R. and Kerbs, E. G. (1995). The MAPK signaling cascade. FASEB J. 9, 726-735.
37. Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P. and Mak, T. W. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39.
38. Sun, H., Lesche, R., Li, D. M., Liliental, J., Zhang, H., Gao, J., Gavrilova, N., Mueller, B., Liu, X. and Wu, H. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 96, 6199-6204.
39. Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M. et al. (2001). T cellspecific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523-534.
40. Vasquez, S. X., Hansen, M. S., Bahadur, A. N., Hockin, M. F., Kindlmann, G. L., Nevell, L., Wu, I. Q., Grunwald, D. J., Weinstein, D. M., Jones, G. M. et al. (2008). Optimization of volumetric computed tomography for skeletal analysis of model genetic organisms. Anat. Rec. 291, 475-487.
41. Vortkamp, A., Lee, K., Lanske, B., Segre, G. V., Kronenberg, H. M. and Tabin, C. J. (1996). Regulation of rate of cartilage differentiation by indian hedgehog and PTH-related protein. Science 273, 613-622.
42. Yang, G., Sun, Q., Teng, Y., Li, F., Weng, T. and Yang, X. (2008). PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1α signaling and endoplasmic reticulum stress. Development 135, 3587-3597.
43. Yeh, L. C., Adamo, M. L., Kitten, A. M., Olson, M. S. and Lee, J. C. (1996). Osteogenic protein-1-mediated insulin-like growth factor gene expression in primary cultures of rat osteoblastic cells. Endocrinology 137, 1921.
44. Yu, K., Xu, J., Liu, Z., Sosic, D., Shao, J., Olson, E. N., Towler, D. A. and Ornitz, D. M. (2003). Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130, 3063-3074.
45. Zhao, M., Harris, S. E., Horn, D., Geng, Z., Nishimura, R., Mundy, G. R. and Chen, D. (2002). Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J. Cell Biol. 157, 1049-1060.